Dainippon Sumitomo Pharma America Selects SAS® Solutions OnDemand
News Nov 03, 2009
SAS has announced that Dainippon Sumitomo Pharma America, Inc. (DSPA), a U.S. pharmaceutical company, has selected SAS Solutions OnDemand: Drug Development as a technology platform for clinical development. With SAS OnDemand, DSPA will have a globally accessible, fully regulatory compliant repository for all of its clinical data.
The SAS OnDemand service has allowed DSPA to move with limited internal resources, in creating its centralized SAS development environment. By letting SAS handle all system provisioning and deployment activities, DSPA resources are free to focus on other mission critical business activities.
SAS Solutions OnDemand: Drug Development is a cost-effective alternative to an enterprise SAS Drug Development implementation, with all embedded enterprise-level content management and analytical capabilities. SAS, through its OnDemand solution, directly supports all hardware and software installation, system administration, validation and maintenance, freeing DSPA from these burdensome responsibilities.
Researchers Fine-Tune Computer-Assisted Drug Repositioning Process to Treat Rare DiseasesNews
Researchers at the LSU Computational Systems Biology group have developed a sophisticated and systematic way to identify existing drugs that can be repositioned to treat a rare disease or condition.READ MORE
Study Extends Potential of Personalized Cell-based ImmunotherapiesNews
New methods developed for the study could be applied to devise personalized, cell-based immunotherapies for epithelial ovarian cancer or other types of tumorsREAD MORE
New Chemical Synthesis Process: Synergy of Two Catalysts in One FlaskNews
Researchers report the one-step synthesis of a ketone from an aldehyde by the combination of thiazolium N-heterocyclic carbene and palladium/bisphosphine catalysts in one flask. The two catalysts function in a synergistic manner. This study is expected to lead to new synthesis processes of precursor compounds for medications.READ MORE